Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution.
Nishihori
Taiga
T
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA. taiga.nishihori@moffitt.org
Perkins
Janelle
J
Kim
Jongphil
J
Field
Teresa
T
Pidala
Joseph
J
Roman-Diaz
Jaime
J
Komrokji
Rami S
RS
Fernandez
Hugo F
HF
Anasetti
Claudio
C
Kharfan-Dabaja
Mohamed A
MA
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002066:Busulfan / Q000008:administration & dosage; D005260:Female; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000401:mortality / Q000628:therapy*; D012189:Retrospective Studies; D015996:Survival Rate; D018183:Transplantation Chimera; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D055815:Young Adult
D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine